← Back
$NKTR All transactions

NEKTAR THERAPEUTICS

▼ SELL

$ Value

$19K

Shares

725

Price

$27

Filed

Aug 21

Insider

Name

Zalevsky Jonathan

Title

Chief R&D Officer

CIK

0001789857

Roles

Officer

Transaction Details

Transaction Date

2025-08-19

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

19,668

Footnotes

Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person. | This transaction was executed in multiple trades at prices ranging from $26.19 to $27.15 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer. | On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split. | These stock options were granted on December 13, 2023 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of three years from the date of grant. | The Organization and Compensation Committee of the Board of Directors of the Issuer determined on July 17, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on August 19, 2025 (subject to remaining time-based vesting requirements).

Filing Info

Accession No.

0000950170-25-110775

Form Type

4

Issuer CIK

0000906709

Zalevsky Jonathan's History

Date Ticker Type Value
2026-02-18 NKTR $13K
2026-01-20 NKTR $138K
2025-12-22 NKTR A $0
2025-12-22 NKTR A $0
2025-11-25 NKTR $63K
2025-11-21 NKTR A $0
2025-11-21 NKTR A $0
2025-09-04 NKTR $26K
2025-09-04 NKTR $15K
2025-09-04 NKTR $7K

Other Insiders at NKTR (90d)

Insider Bought Sold Last
ROBIN HOWARD W
President & CEO
$31K 2026-02-18
Zalevsky Jonathan
Chief R&D Officer
$13K 2026-02-18